BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 3027685)

  • 1. [Immunocytochemical demonstration of actin in myothelial cells in proliferative diseases of the breast].
    Walther B; Rutter G; Stegner HE; Böcker W
    Pathologe; 1986 Nov; 7(6):318-23. PubMed ID: 3027685
    [No Abstract]   [Full Text] [Related]  

  • 2. New aspects of the natural history of in situ and invasive carcinoma in the female breast. Results from autopsy investigations.
    Andersen J; Nielsen M; Christensen L
    Verh Dtsch Ges Pathol; 1985; 69():88-95. PubMed ID: 3006395
    [No Abstract]   [Full Text] [Related]  

  • 3. [Morphology, topography and growth pattern of benign proliferative breast lesions and pre-invasive cancers].
    Böcker W; Jarasch ED; Nagle EB; Höhne R
    Verh Dtsch Ges Pathol; 1985; 69():96-107. PubMed ID: 3006396
    [No Abstract]   [Full Text] [Related]  

  • 4. [Significance of hyperelastosis in proliferative lesions of the breast].
    Cuccurullo L; Giordano GG; Mineo A; Iaccarino M; Battista O; Cattaneo L; Ferraraccio F
    Pathologica; 1984; 76(1041):89-101. PubMed ID: 6087264
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pre-invasive tumors and precancerous conditions of the breast: pathologico-anatomic demarcation and clinical consequences].
    Bässler R; Werner J
    Chirurg; 1984 Mar; 55(3):133-41. PubMed ID: 6325099
    [No Abstract]   [Full Text] [Related]  

  • 6. [Histopathology of the breast with reference to consultant studies. II. On the diagnosis and differential diagnosis of non-neoplastic diseases and tumors].
    Bässler R; Kronsbein H; Schneider B
    Pathologe; 1989 May; 10(3):142-59. PubMed ID: 2544866
    [No Abstract]   [Full Text] [Related]  

  • 7. The pathologic profile of invasive breast cancer-ii) changes in the harboring mammary tissue and regional lymphnodes.
    Mehtani VG; Joshi K; Mehrotra GC
    Indian J Pathol Microbiol; 1987 Oct; 30(4):415-22. PubMed ID: 2853136
    [No Abstract]   [Full Text] [Related]  

  • 8. [Symptomology of non-invasive proliferative epithelial changes in the breast].
    Geppert M; Bachmann FF
    Med Welt; 1982 Jul; 33(28):1020-3. PubMed ID: 6289038
    [No Abstract]   [Full Text] [Related]  

  • 9. [Histopathology of the breast with reference to consultant studies. I. An analysis of 1,339 cases on the breast register of the Fulda Pathologic Institute].
    Bässler R; Schneider B; Scheidt E
    Pathologe; 1989 May; 10(3):135-41. PubMed ID: 2544865
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunohistochemical breast cancer diagnosis].
    Schauer A; Brehler R; Bergholz M
    Verh Dtsch Ges Pathol; 1985; 69():171-86. PubMed ID: 2420086
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunohistochemical evidence of vimentin in fibrocystic breast disease and mammary carcinoma].
    Alexiev B; Valkov I; Popov A
    Zentralbl Pathol; 1992 Sep; 138(4):284-8. PubMed ID: 1329942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the patterns of laminin expression in fibroadenoma, fibrocystic diseases, pre-invasive and invasive ductal breast carcinoma.
    Zheng WQ; Looi LM; Cheah PL
    Pathology; 2001 Aug; 33(3):303-6. PubMed ID: 11523929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of cytology for diagnosis of breast cancer].
    Tessmann D; Pommerenke F
    Z Arztl Fortbild (Jena); 1990; 84(14):719-21. PubMed ID: 2176017
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diseases of the female breast: clinical pathology].
    Torhorst J
    Ther Umsch; 1993 May; 50(5):307-13. PubMed ID: 8397447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
    Ariga N; Moriya T; Suzuki T; Kimura M; Ohuchi N; Satomi S; Sasano H
    Anticancer Res; 2000; 20(2B):1101-8. PubMed ID: 10810403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Massive myoepithelial proliferation (myoepitheliosis) with lumpy deposits of basement membrane material closely associated with apocrine adenosis and ductal carcinoma in situ of the breast.
    Kawasaki T; Oyama T; Nakagomi H; Furuya K; Kondo T; Nakazawa T; Mochizuki K; Yamane T; Miyazawa T; Ishii Y; Fukushima K; Moriya T; Tsunoda H; Katoh R
    Pathol Int; 2011 Oct; 61(10):615-7. PubMed ID: 21951673
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathologic considerations in the high-risk breast patient.
    Simmons R; Serafin D; McCarty K
    Clin Plast Surg; 1988 Oct; 15(4):655-65. PubMed ID: 2852084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinico-morphological parallels in different histological variants of breast cancer].
    Belikov GN
    Khirurgiia (Mosk); 1983 Nov; (11):48-52. PubMed ID: 6319796
    [No Abstract]   [Full Text] [Related]  

  • 19. [Procedures of analytic morphometry in the monitoring of nuclear changes of breast ductal epithelium from normal to carcinoma].
    Giardina C; Serio G; Potente F; Pennella A; Lettini T; Di Tolve P; Ricco R; Pesce Delfino V
    Pathologica; 1992; 84(1094):97-100. PubMed ID: 1338654
    [No Abstract]   [Full Text] [Related]  

  • 20. [Relation of cell proliferation to regression with special reference to epithelial tumors].
    Stifns R; Klotz D
    Verh Dtsch Ges Pathol; 1985; 69():274-8. PubMed ID: 3006382
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.